ALS Ltd. (CPBLF) Gets a Buy from Jarden
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 22 2024
0mins
Source: Business Insider
Analyst Ratings: Jakob Cakarnis from Jarden maintains a Buy rating on ALS Ltd. with a price target of A$14.20, while Jefferies also rates it as a Buy with a higher target of A$16.90, indicating strong analyst support for the stock.
Company Performance: ALS Ltd. reported a quarterly revenue of $25.2 billion and a GAAP net loss of $346 million, contrasting with last year's profit of $1.12 billion, though insider sentiment remains positive with increased share purchases by insiders.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
